Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Loss of Llgl1 in retinal neuroepithelia reveals links between apical domain size, Notch activity and neurogenesis.

Development (Cambridge, England) | 2012

To gain insights into the cellular mechanisms of neurogenesis, we analyzed retinal neuroepithelia deficient for Llgl1, a protein implicated in apicobasal cell polarity, asymmetric cell division, cell shape and cell cycle exit. We found that vertebrate retinal neuroepithelia deficient for Llgl1 retained overt apicobasal polarity, but had expanded apical domains. Llgl1 retinal progenitors also had increased Notch activity and reduced rates of neurogenesis. Blocking Notch function by depleting Rbpj restored normal neurogenesis. Experimental expansion of the apical domain, through inhibition of Shroom3, also increased Notch activity and reduced neurogenesis. Significantly, in wild-type retina, neurogenic retinal progenitors had smaller apical domains compared with proliferative neuroepithelia. As nuclear position during interkinetic nuclear migration (IKNM) has been previously linked with cell cycle exit, we analyzed this phenomenon in cells depleted of Llgl1. We found that although IKNM was normal, the relationship between nuclear position and neurogenesis was shifted away from the apical surface, consistent with increased pro-proliferative and/or anti-neurogenic signals associated with the apical domain. These data, in conjunction with other findings, suggest that, in retinal neuroepithelia, the size of the apical domain modulates the strength of polarized signals that influence neurogenesis.

Pubmed ID: 22492354 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

  • Agency: NEI NIH HHS, United States
    Id: T32EY014536
  • Agency: NEI NIH HHS, United States
    Id: P30EY001931
  • Agency: NEI NIH HHS, United States
    Id: R01EY014167
  • Agency: NEI NIH HHS, United States
    Id: R01 EY014167
  • Agency: NCI NIH HHS, United States
    Id: R01CA131047
  • Agency: NCI NIH HHS, United States
    Id: R01 CA131047
  • Agency: NCI NIH HHS, United States
    Id: R01 CA098161
  • Agency: NEI NIH HHS, United States
    Id: T32 EY014537
  • Agency: NCI NIH HHS, United States
    Id: R01CA098161
  • Agency: NEI NIH HHS, United States
    Id: P30 EY001931
  • Agency: NCI NIH HHS, United States
    Id: P30 CA015704
  • Agency: NEI NIH HHS, United States
    Id: T32 EY014536

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


zs-4 (antibody)

RRID:AB_10013814

This monoclonal targets zs-4

View all literature mentions